Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2–5 years: A phase III study

Liwei Shi, Jingjing Chen, Hong Li, Xuemei Yan, Fang Shen, Xin Lai, Lin Yuan, Yi Mo

Open source

DOI
10.1016/j.vaccine.2026.128244
Published
2026-03
Container
Vaccine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.128244,
  title = {Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2–5 years: A phase III study},
  author = {Liwei Shi and Jingjing Chen and Hong Li and Xuemei Yan and Fang Shen and Xin Lai and Lin Yuan and Yi Mo},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.128244},
  url = {https://doi.org/10.1016/j.vaccine.2026.128244}
}

RIS

TY  - JOUR
TI  - Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2–5 years: A phase III study
AU  - Liwei Shi
AU  - Jingjing Chen
AU  - Hong Li
AU  - Xuemei Yan
AU  - Fang Shen
AU  - Xin Lai
AU  - Lin Yuan
AU  - Yi Mo
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.128244
UR  - https://doi.org/10.1016/j.vaccine.2026.128244
ER  - 

APA

Shi, L., Chen, J., Li, H., Yan, X., Shen, F., Lai, X., Yuan, L., & Mo, Y. (2026). Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2–5 years: A phase III study. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128244

Source records